Cholesterol Disorders

 
Stroke Patients Very Likely to Present with Undiagnosed Risk Factors
June 30, 2022

Three-quarters of stroke patients in a Swiss registry had at least 1 undiagnosed risk factor at the time of the event, most commonly hyperlipidemia or hypertension.

US Cardiovascular Health Remains Poor, Declines Begin in Early Childhood: American Heart Association Investigators
June 29, 2022

US CV health is well below ideal, with 80% of adults scoring as only low or moderate in the first published study using AHA's new Life's Essential 8 algorithm.

American Heart Association Announces "Life's Essential 8" Enhanced Cardiovascular Health Model
June 29, 2022

Slide Show: The AHA added sleep duration to its Life's Simple 7 cardiovascular health construct and updated sections on diet, lipids, blood glucose and smoking.

Meta-Analysis: Current Evidence on Statin Impact on LDL-C and CVD Risk Reduction is Flawed
March 21, 2022

A new meta-analysis questions the science demonstrating the link between statin-induced LDL-C lowering and improved CV, all-cause outcomes.

Oral PCSK9 Inhibitor Significantly Reduced High Levels of Cholesterol in Phase 1 Trials
November 18, 2021

AHA 2021: New research showed MK-0616, an investigative oral PCSK9 inhibitor, was associated with a near 65% decrease in LDL-C.

Remote Program Improves Blood Pressure and Cholesterol in High-risk Patients
November 16, 2021

AHA 2021: Study suggests remote hypertension and hyperlipidemia management programs may expand telehealth delivery, increase access to care, and reduce health inequities.

Sustained Weight Loss May Reverse CV Risk Factors Linked to Obesity, Study Shows
September 28, 2021

EASD 2021: For persons who have had obesity, returning to a healthy weight may reduce risk for hypertension and dyslipidemia, and modestly for diabetes.

Women with T2D Less Likely to Receive Guideline-recommended Cardiovascular Care vs Men
September 28, 2021

EASD 2021: Women with type 2 diabetes were less likely to meet targets for CV risk management vs men but at lower risk for future CV events, a new study found.

Early LDL-C Exposure and Cumulative Burden Increase CHD Risk in Middle Age
September 24, 2021

Clinical decisions on LDL-C management currently rely on a measure at one time point, typically middle age. A new study suggests burden begins early and so should assessment.

Preventive Cardiology after Framingham: Nathan D. Wong, PhD, MPH, Details the Evolution
July 28, 2021

Nathan D Wong, PhD, MPH, renowned in the field of preventive cardiology, reviewed for Patient Care the history of the field and his own pivotal contributions and also paid tribute to his lifetime mentors.